CYCLO3PSS CORP
S-3, EX-5, 2000-08-18
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CYCLO3PSS CORP, S-3, EX-4, 2000-08-18
Next: CYCLO3PSS CORP, S-3, EX-23, 2000-08-18






                           COHNE, RAPPAPORT & SEGAL
                        525 East 100 South, Fifth Floor
                           Salt Lake City, UT 84102
                                 (801) 532-266
                              Fax: (801) 355-1813


August 18, 2000

Board of Directors
Cyclo3pss Corporation
3646 West 2100 South
Salt Lake City, UT 84120

     Re:  Opinion Letter and Consent
          Registration Statement on Form S-3

Gentlemen:

      We are acting as Securities Counsel for Cyclo3pss Corporation  ("Company")
with  respect  to  the  Registration   Statement  on  Form  S-3   ("Registration
Statement"),  filed by the Company with the Securities  and Exchange  Commission
for the purpose of  registering  under the  Securities  Act of 1933, as amended,
3,573,024 shares of Common Stock ("Common Stock"),  $.001 par value, issuable to
the  "Selling  Stockholder"  upon  the  Selling  Stockholder's  conversion  of a
Convertible Promissory Note

      We are of the opinion  that the said  Common  Stock when  issued,  will be
legally  issued,  fully  paid and  nonassessable,  except as may be  limited  by
bankruptcy, insolvency, moratorium or other similar laws or equitable principles
relating to or limiting creditors' rights generally.

      We consent to the filing of this opinion as an exhibit to the Registration
Statement  on Form S-3 and to the  reference  to us  under  the  caption  "Legal
Opinion" in the Prospectus which is a part of the Registration Statement.

                                    Very truly yours,

                                    COHNE, RAPPAPORT & SEGAL


                                    BY: /s/ A. O. Headman Jr.
                                    ----------------------------
                                          A. O. Headman, Jr.


                                      33



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission